ZyVersa Therapeutics, Inc. disclosed financial information and operating metrics for its fourth quarter and fiscal year ended December 31, 2022 and discussed its business outlook.
AI Assistant
ZYVERSA THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.